Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-09-16
1996-02-13
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530311, 530327, A61K 3800, C07K 708, C07K 700
Patent
active
054911311
ABSTRACT:
Pharmaceutical compositions for use in the prevention or treatment of diseases and dysfunctions associated with pathological contraction of mesangial cells and other contractile cells responsive to angiotensin II and/or oxygen free radicals, comprise as an active ingredient one or more somatostatin-active polypeptides. The somatostatins are particularly useful for the treatment or prevention of renal dysfunction.
REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4728638 (1988-03-01), Bauer et al.
Remington's Pharmaceutical Science, Mack Publising Co. 16th Edition, pp. 654-655. 1980.
Limberg, et al, New England Journal of Medicine, vol. 303, No. 5, (1980) 284.
Mountokalakis, et al, Nephrology Dialysis Transplantation, 1988, 3:604-607.
Chemical Abstracts, vol. 103, 1985.
Chemical Abstracts vol. 96, 1982.
Chemical Abstracts vol. 101, 1984.
Chemical Abstracts vol. 97, 1982.
Sizonenko, Endocrinological Control of Growth, Postgrad, Med. J. 1978, Suppl. 1, 91.
Ashton et al-Br. J. Clin. Pharmac. 1976, 3, 523.
Inverson et al, Nature, 1978, 273 161.
Lins et al-Lancet 1978, 2, 687.
John Gerich, Archs. Intern. Med. 1977, 137 659.
G. M. Besser et al-Lancet 1975 1, 1166.
S. E. Christensen et al-Lancet, 1975 1 1426.
Sidman et al, Journal of Membrane Science 7 (1980) 277-291.
Misra, American Journal of Clinical Pathology, pp. 135-139.
S. A. Jenkins et al, Klinische Wochenschrift, 1986, 64, 100-106.
Thomas G. Murray et al, J. Int. Med. Res (1981) 9, 1.
P. N. Maton et al, The New England Journal of Medicine, vol. 312, No. 1, (1985) 17-21.
Creutzfeldt et al, World J. Surg., vol. 5, No. 3, 341-350 (1981).
R. Lugari et al, Proc. EDTA-ERS, vol. 21, 1984, pp. 614-617.
Halma et al, Annals of Internal Medicine, vol. 107, No. 4 (1987) pp. 518-520.
Puyol Diego R.
Puyol Manuel R.
Applied Research Systems ARS Holding NV
Marshall S. G.
Warden Jill
LandOfFree
Somatostatin-active polypeptide composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Somatostatin-active polypeptide composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Somatostatin-active polypeptide composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-240612